- Global
- United States
- Australia
- United Kingdom
- Canada
- India
- China
- Argentina
- Austria
- Bahrain
- Bangladesh
- Belgium
- Bermuda
- Botswana
- Brazil
- Bulgaria
- Chile
- Colombia
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Egypt
- Estonia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Ireland
- Israel
- Italy
- Ivory Coast
- Jamaica
- Japan
- Jordan
- Kenya
- Kuwait
- Latvia
- Lithuania
- Luxembourg
- Malawi
- Malaysia
- Malta
- Mauritius
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Oman
- Pakistan
- Palestinian Authority
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Trinidad & Tobago
- Tunisia
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- Venezuela
- Vietnam
- Zambia
- Zimbabwe
🌎 Switch to Global Market
Pharmaceuticals & Biotech Austrian Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech Austrian Investing Ideas
There are no community narratives available.
Recently Updated Narratives
AS
Strategic pivot in maximizing corporate value
Fair Value: JP¥928.16 2.6% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
FI
Why Marcus Lemonis will acquire BARK
Fair Value: US$1.4 43.9% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
DH
Paladin Energy: Betting on the Nuclear Renaissance
Fair Value: AU$1.87 563.1% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
KA
Nu holdings will continue to disrupt the South American banking market
Fair Value: US$64.3 76.9% undervalued intrinsic discount
6k viewsusers have viewed this narrative
51 followersusers have followed this narrative
3 commentsusers have commented on this narrative
27 likesusers have liked this narrative
AN
Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
Fair Value: US$596 31.9% undervalued intrinsic discount
6.5k viewsusers have viewed this narrative
1306 followersusers have followed this narrative
2 commentsusers have commented on this narrative
10 likesusers have liked this narrative
AN
NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
Fair Value: US$253.02 27.0% undervalued intrinsic discount
11.6k viewsusers have viewed this narrative
1103 followersusers have followed this narrative
7 commentsusers have commented on this narrative
34 likesusers have liked this narrative
